新型冠状病毒肺炎疫情防控常态化下中医药临床研究实践与管理的思考

Thoughts on practice and management of clinical research of traditional Chinese medicine during normalization stage of prevention and control of COVID-19

自新型冠状病毒肺炎(简称“新冠肺炎”)疫情发生以来,中医药在新冠肺炎防治中发挥了独特疗效,同时,新冠肺炎疫情也给中医药临床研究带来了机遇与重大的挑战。通过梳理并分析新冠肺炎疫情防控常态化下关于新冠肺炎中医药临床研究实践与管理中存在的问题,对中医药临床研究的选题与立项、方案设计、医学伦理审查、研究实施、科研管理等方面进行思考和探索,以期为疫情期间新冠肺炎中医药临床研究项目科学、规范地实施提供若干建议。

Since the outbreak of novel coronavirus disease(COVID-19),traditional Chinese medicine(TCM)has been playing a unique role in the prevention and treatment of COVID-19. Meanwhile,the COVID-19 pandemic has brought opportunities and significant challenges to the TCM clinical research. By reviewing and analyzing the problems in the practice and management of TCM clinical research on COVID-19 during the normalization stage of pandemic prevention and control,we aim to explore and discuss the topic selection and project initiation,protocol design,ethical review,research implementation,and research management of TCM clinical research in this article,with a view to providing some suggestions for the scientific and standardized conduct of TCM clinical research on COVID-19 during the pandemic.